Literature DB >> 12553370

A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?

E Hormbrey1, P Gillespie, K Turner, C Han, A Roberts, D McGrouther, A L Harris.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent angiogenic growth factor with a key role in many physiological and pathological processes. Investigation into the implications of circulating levels of this cytokine is progressing at an exponential rate. However, there are important inconsistencies between reports ranging from method of sample collection, processing, software manipulation and data interpretation and controversy as to whether plasma, serum or whole blood will provide the best prognostic information. Different techniques of centrifugation and temperature on sample handling and the impact of in vitro collection of blood on subsequent VEGF results have not been fully appreciated. We provide a critical review of the literature, report the results of our further investigations, suggest a uniform protocol for handling blood samples and highlight previously unsuspected problems in data interpretation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553370     DOI: 10.1023/a:1021379811308

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  64 in total

1.  Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo.

Authors:  A Weltermann; M Wolzt; K Petersmann; C Czerni; U Graselli; K Lechner; P A Kyrle
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-07       Impact factor: 8.311

2.  Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?

Authors:  M L George; S A Eccles; M G Tutton; A M Abulafi; R I Swift
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

3.  Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.

Authors:  P Salven; A Orpana; H Joensuu
Journal:  Clin Cancer Res       Date:  1999-03       Impact factor: 12.531

4.  Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.

Authors:  C A Chen; W F Cheng; C N Lee; T M Chen; C C Kung; F J Hsieh; C Y Hsieh
Journal:  Gynecol Oncol       Date:  1999-08       Impact factor: 5.482

5.  In vitro release of vascular endothelial growth factor during platelet aggregation.

Authors:  J P Maloney; C C Silliman; D R Ambruso; J Wang; R M Tuder; N F Voelkel
Journal:  Am J Physiol       Date:  1998-09

6.  Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract.

Authors:  M Braga; L Gianotti; A Vignali; O Gentilini; P Servida; C Bordignon; V Di Carlo
Journal:  Br J Surg       Date:  1995-12       Impact factor: 6.939

7.  Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis.

Authors:  S B Fox; R D Leek; M P Weekes; R M Whitehouse; K C Gatter; A L Harris
Journal:  J Pathol       Date:  1995-11       Impact factor: 7.996

8.  Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.

Authors:  A Kraft; K Weindel; A Ochs; C Marth; J Zmija; P Schumacher; C Unger; D Marmé; G Gastl
Journal:  Cancer       Date:  1999-01-01       Impact factor: 6.860

Review 9.  Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy.

Authors:  A L Harris
Journal:  Recent Results Cancer Res       Date:  1998

10.  Serum vascular endothelial growth factor load and interleukin-6 in cancer patients.

Authors:  K J O'Byrne; N Dobbs; A L Harris
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

View more
  24 in total

1.  Angiogenic factors in serum of patients with testicular germ cell tumours.

Authors:  Simone Ferrero
Journal:  Urol Res       Date:  2004-05-19

2.  Serum VEGF, blood transfusion, and wound orientation : Letter re: Belizon et al. Surg Endosc. 2008 Jan 18.

Authors:  G F Nash
Journal:  Surg Endosc       Date:  2008-07-23       Impact factor: 4.584

3.  Stability analysis of vascular endothelial growth factor in cerebrospinal fluid.

Authors:  Jun Yang; Stephen M Dombrowski; Abhishek Deshpande; Natalie Krajcir; Serge El-Khoury; Chandra Krishnan; Mark G Luciano
Journal:  Neurochem Res       Date:  2011-06-04       Impact factor: 3.996

Review 4.  Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug development.

Authors:  Jean W Lee; Marian Kelley; Lindsay E King; Jihong Yang; Hossein Salimi-Moosavi; Meina T Tang; Jian-Feng Lu; John Kamerud; Ago Ahene; Heather Myler; Cindy Rogers
Journal:  AAPS J       Date:  2011-01-15       Impact factor: 4.009

5.  Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer.

Authors:  Tina Wiesner; Stefanie Bugl; Frank Mayer; Jörg T Hartmann; Hans-Georg Kopp
Journal:  Clin Exp Metastasis       Date:  2010-02-25       Impact factor: 5.150

6.  Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.

Authors:  Janice M Mehnert; Mary M McCarthy; Lucia Jilaveanu; Keith T Flaherty; Saadia Aziz; Robert L Camp; David L Rimm; Harriet M Kluger
Journal:  Hum Pathol       Date:  2009-12-11       Impact factor: 3.466

7.  Association of plasma VEGF-A, soluble VEGFR-1 and VEGFR-2 levels and clinical response and survival in advanced colorectal cancer patients receiving bevacizumab with modified FOLFOX6.

Authors:  Yoshiko Aoyagi; Hisae Iinuma; Atsushi Horiuchi; Ryu Shimada; Toshiaki Watanabe
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

8.  Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.

Authors:  Mansour-S Al-Moundhri; A Al-Shukaili; M Al-Nabhani; B Al-Bahrani; I-A Burney; A Rizivi; S-S Ganguly
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

9.  The relation of serum vascular endothelial growth factor level with disease duration and activity in patients with rheumatoid arthritis.

Authors:  Levent Ozgonenel; Esra Cetin; Sule Tutun; Pinar Tonbaklar; Hale Aral; Guvenc Guvenen
Journal:  Clin Rheumatol       Date:  2010-01-13       Impact factor: 2.980

10.  Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability.

Authors:  Meta Michels; André J A M van der Ven; Kis Djamiatun; Rob Fijnheer; Philip G de Groot; Arjan W Griffioen; Silvie Sebastian; Sultana M H Faradz; Quirijn de Mast
Journal:  Am J Trop Med Hyg       Date:  2012-09-04       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.